{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:46:08Z","timestamp":1785815168224,"version":"3.56.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T00:00:00Z","timestamp":1545955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Programme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,7]]},"DOI":"10.1093\/eurheartj\/ehy812","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T20:17:15Z","timestamp":1542140235000},"page":"180-186","source":"Crossref","is-referenced-by-count":191,"title":["Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data"],"prefix":"10.1093","volume":"40","author":[{"given":"Frederik M","family":"Zimmermann","sequence":"first","affiliation":[{"name":"Department of Cardiology, Catharina Hospital, Michelangelolaan 2, EJ Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmir","family":"Omerovic","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sahlgrenska University Hospital, Bl\u00e5 str\u00e5ket 5, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Fournier","sequence":"additional","affiliation":[{"name":"Cardiovascular Center Aalst, OLV-Clinic, Moorselbaan, Aalst, Belgium"},{"name":"Department of Cardiology, Lausanne University Center Hospital, Rue du Bugnon 46, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Kelb\u00e6k","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zealand University Hospital, Sygehusvej 10, Roskilde, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils P","family":"Johnson","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Weatherhead PET Center, McGovern Medical School, UTHealth and Memorial Hermann Hospital, Fannin Street, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rothenb\u00fchler","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, University of Bern, Mittelstrasse 43, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Xaplanteris","sequence":"additional","affiliation":[{"name":"Cardiovascular Center Aalst, OLV-Clinic, Moorselbaan, Aalst, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Wahab","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Heart Center, Segeberger Am Kurpark 1, Bad Segeberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[{"name":"Cardiovascular Center Aalst, OLV-Clinic, Moorselbaan, Aalst, Belgium"},{"name":"Department of Advanced Biomedical Science, University of Naples Federico II, Via Pansini, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan Eik","family":"H\u00f8fsten","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim A L","family":"Tonino","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Catharina Hospital, Michelangelolaan 2, EJ Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca M","family":"Boxma-de Klerk","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maasstad Ziekenhuis, Maasstadweg 21, DZ Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F","family":"Fearon","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Stanford University, Stanford, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter C","family":"Smits","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Maasstad Ziekenhuis, Maasstadweg 21, DZ Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"De Bruyne","sequence":"additional","affiliation":[{"name":"Cardiovascular Center Aalst, OLV-Clinic, Moorselbaan, Aalst, Belgium"},{"name":"Department of Cardiology, Lausanne University Center Hospital, Rue du Bugnon 46, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico H J","family":"Pijls","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Catharina Hospital, Michelangelolaan 2, EJ Eindhoven, The Netherlands"},{"name":"Department of Biomedical Engineering, Eindhoven University of Technology, MB Eindhoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"J\u00fcni","sequence":"additional","affiliation":[{"name":"Applied Health Research Centre, Li Ka Shing Knowledge Institute of St Michael's Hospital, Department of Medicine, University of Toronto, Medical Sciences Building, 1 King's College Cir, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Engstr\u00f8m","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen, Denmark"},{"name":"Department of Cardiology, University of Lund, EA-blocket, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,28]]},"reference":[{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B1","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1161\/CIR.0000000000000095","article-title":"2014 ACC\/AHA\/AATS\/PCNA\/SCAI\/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","volume":"130","author":"Fihn","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B2","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","article-title":"2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B3","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","article-title":"Fractional flow reserve-guided PCI for stable coronary artery disease","volume":"371","author":"De Bruyne","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(15)60648-1","article-title":"Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3\u2014PRIMULTI): an open-label, randomized controlled trial","volume":"386","author":"Engstr\u00f8m","year":"2015","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1701067","article-title":"Fractional flow reserve-guided multivessel angioplasty in myocardial infarction","volume":"376","author":"Smits","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJMe1208620","article-title":"Which is more enduring\u2013FAME or COURAGE?","volume":"367","author":"Boden","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B7","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1056\/NEJMoa1803538","article-title":"Five-year outcomes with PCI guided by fractional flow reserve","volume":"379","author":"Xaplanteris","year":"2018","journal-title":"N Eng J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B8","doi-asserted-by":"crossref","first-page":"e004665","DOI":"10.1161\/CIRCOUTCOMES.118.004665","article-title":"Moving the goalposts into unblinded territory: the larger lessons of DEFER and FAME 2 and their implications for shifting end points in ISCHEMIA","volume":"11","author":"Rajkumar","year":"2018","journal-title":"Circ Cardiovasc Qual Outcome"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B9","doi-asserted-by":"crossref","first-page":"e004742","DOI":"10.1161\/CIRCOUTCOMES.118.004742","article-title":"Letter by Hochman and Maron Regarding Article, \u201c\u2018Faith Healing\u2019 and \u2018Subtraction Anxiety\u2019 in Unblinded Trials of Procedures: lessons From DEFER and FAME-2 for End Points in the ISCHEMIA Trial\u201d","volume":"11","author":"Hochman","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B10","doi-asserted-by":"crossref","first-page":"e004791.","DOI":"10.1161\/CIRCOUTCOMES.118.004791","article-title":"ISCHEMIA: establishing the Primary End Point","volume":"11","author":"Bangalore","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B11","doi-asserted-by":"crossref","first-page":"d5928.","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B12","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD Statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2010.04.012","article-title":"Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study","volume":"56","author":"Pijls","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B14","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-12-34","article-title":"Individual patient data meta-analysis of survival data using Poisson regression models","volume":"12","author":"Crowther","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B15","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1002\/sim.6191","article-title":"Multilevel mixed effects parametric survival models using adaptive Gauss-Hermite quadrature with application to recurrent events and individual participant data meta-analysis","volume":"33","author":"Crowther","year":"2014","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B16","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","article-title":"Calculating the number needed to treat for trials where the outcome is time to an event","volume":"319","author":"Altman","year":"1999","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/ije\/dyr041","article-title":"The Simpson's paradox unraveled","volume":"40","author":"Hern\u00e1n","year":"2011","journal-title":"Int J Epidemiol"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B18","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/sim.7171","article-title":"One-stage individual participant data meta-analysis models: estimation of treatment-covariate interactions must avoid ecological bias by separating out within-trial and across-trial information","volume":"36","author":"Hua","year":"2017","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B19","doi-asserted-by":"crossref","first-page":"e59202.","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B20","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/eurheartj\/ehu424","article-title":"Systematic reviews and meta-analyses of randomized trials: principles and pitfalls","volume":"35","author":"da Costa","year":"2014","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jcin.2014.12.221","article-title":"Randomized comparison of FFR-guided and angiography-guided provisional stenting of true coronary bifurcation lesions: the DKCRUSH-VI trial (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI)","volume":"8","author":"Chen","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurheartj\/ehu338","article-title":"Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial","volume":"36","author":"Layland","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B23","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1700445","article-title":"Use of the instantaneous wave-free ratio or fractional flow reserve in PCI","volume":"376","author":"Davies","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B24","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa1616540","article-title":"Instantaneous wave-free ratio versus fractional flow reserve to guide PCI","volume":"376","author":"G\u00f6tberg","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without PCI for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B27","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1093\/eurheartj\/ehv452","article-title":"Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial","volume":"36","author":"Zimmermann","year":"2015","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B28","doi-asserted-by":"crossref","first-page":"e002442","DOI":"10.1161\/CIRCINTERVENTIONS.115.002442","article-title":"Long-term clinical outcomes of fractional flow reserve-guided versus routine drug-eluting stent implantation in patients with intermediate coronary stenosis: five-year clinical outcomes of DEFER-DES trial","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B29","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B30","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJMoa1305520","article-title":"Randomized trial of preventive angioplasty in myocardial infarction","volume":"369","author":"Wald","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B31","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jacc.2014.12.038","article-title":"Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial","volume":"65","author":"Gershlick","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B32","doi-asserted-by":"crossref","first-page":"968","DOI":"10.4244\/EIJV5I8A162","article-title":"Non-culprit lesions detected during primary PCI: treat invasively or follow the guidelines?","volume":"5","author":"Dambrink","year":"2010","journal-title":"EuroIntervention"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B33","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B34","doi-asserted-by":"crossref","first-page":"g3859.","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B35","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2014.07.987","article-title":"Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction","volume":"64","author":"Cuculi","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcin.2010.08.025","article-title":"Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction","volume":"3","author":"Ntalianis","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2017.07.017","article-title":"Instantaneous wave-free ratio and fractional flow reserve for the assessment of nonculprit lesions during the index procedure in patients with ST-segment elevation myocardial infarction: the WAVE study","volume":"193","author":"Musto","year":"2017","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jcin.2017.11.028","article-title":"Influence of local myocardial damage on index of microcirculatory resistance and fractional flow reserve in target and nontarget vascular territories in a porcine microvascular injury model","volume":"11","author":"Lee","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B39","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jacc.2015.03.003","article-title":"Benefits and risks of extended duration dual antiplatelet therapy after PCI in patients with and without acute myocardial infarction","volume":"65","author":"Yeh","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t2019010703585566500_ehy812-B40","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy658","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","author":"Neumann","year":"2018","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/40\/2\/180\/27397909\/ehy812.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T22:31:18Z","timestamp":1662417078000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/40\/2\/180\/5265290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,28]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,12,28]]},"published-print":{"date-parts":[[2019,1,7]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehy812","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,7]]},"published":{"date-parts":[[2018,12,28]]}}}